Abstract
Objective: To investigate nephroprotective potential of Urtica parviflora (UP) against paracetamol (PCM) induced nephrotoxicity in rats.
Methods: Nephrotoxicity was induced in rats by chronic administration of PCM (1 g/kg body weight p.o.) for 21 days. Different doses of UP (250, 500 and 750 mg/kg b.w., p.o.) were administered for 21 days along with PCM. Blood urea, blood urea nitrogen (BUN), serum creatinine, total protein, serum and tissue nitrite, renal enzymatic and non-enzymatic antioxidants along with lipid peroxidation were evaluated. The effect of extract treatment on the renal histopathological profile in PCM nephrotoxic rats was also evaluated.
Results: PCM treatment significantly elevated blood urea, BUN, creatinine, serum nitrite and renal lipid peroxidation along with significant decrement in renal enzymatic and non-enzymatic antioxidants, total proteins while UP treatment significantly attenuated these alterations. The extract was also effective in mitigating renal histopathological changes induced by PCM.
Conclusions: The results suggested potent nephroprotective and antioxidant properties of Urtica parviflora.
Keywords: Urtica parviflora, paracetamol, nephrotoxicity, antioxidant activity, enzymatic, non-enzymatic, lipid, serum, protien, antioxidant.
The Natural Products Journal
Title:Nephroprotective Potential of Urtica parviflora Roxb. Against Paracetamol Induced Nephrotoxicity in Rats
Volume: 2 Issue: 4
Author(s): Savita Pandey, Sangeeta P. Sah and Anita Singh
Affiliation:
Keywords: Urtica parviflora, paracetamol, nephrotoxicity, antioxidant activity, enzymatic, non-enzymatic, lipid, serum, protien, antioxidant.
Abstract: Objective: To investigate nephroprotective potential of Urtica parviflora (UP) against paracetamol (PCM) induced nephrotoxicity in rats.
Methods: Nephrotoxicity was induced in rats by chronic administration of PCM (1 g/kg body weight p.o.) for 21 days. Different doses of UP (250, 500 and 750 mg/kg b.w., p.o.) were administered for 21 days along with PCM. Blood urea, blood urea nitrogen (BUN), serum creatinine, total protein, serum and tissue nitrite, renal enzymatic and non-enzymatic antioxidants along with lipid peroxidation were evaluated. The effect of extract treatment on the renal histopathological profile in PCM nephrotoxic rats was also evaluated.
Results: PCM treatment significantly elevated blood urea, BUN, creatinine, serum nitrite and renal lipid peroxidation along with significant decrement in renal enzymatic and non-enzymatic antioxidants, total proteins while UP treatment significantly attenuated these alterations. The extract was also effective in mitigating renal histopathological changes induced by PCM.
Conclusions: The results suggested potent nephroprotective and antioxidant properties of Urtica parviflora.
Export Options
About this article
Cite this article as:
Pandey Savita, P. Sah Sangeeta and Singh Anita, Nephroprotective Potential of Urtica parviflora Roxb. Against Paracetamol Induced Nephrotoxicity in Rats, The Natural Products Journal 2012; 2 (4) . https://dx.doi.org/10.2174/2210315511202040316
DOI https://dx.doi.org/10.2174/2210315511202040316 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chronobiological Approaches to Alzheimers Disease
Current Alzheimer Research Network Pharmacology Analysis on Zhichan Powder in the Treatment of Parkinson's Disease
Combinatorial Chemistry & High Throughput Screening The Therapeutic Value of Natural Agents to Treat miRNA Targeted Breast Cancer in African-American and Caucasian-American Women
Current Drug Targets Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
Current Neurovascular Research Biphenyl-Derivatives Possessing Tertiary Amino Groups as β-Secretase (BACE1) Inhibitors
Letters in Drug Design & Discovery A Comparison of Non-Human Primate Cytochrome P450 2D Members and the Implication in Drug Discovery
Current Drug Metabolism Aberrant Expression of MicroRNAs in B-cell Lymphomas
MicroRNA Magnetite Polycitric Acid (Fe3O4@PCA) Nanoparticles: A Novel, Efficient and Reusable Solid Acid Catalyst for the Preparation of Polyhydroquinolines
Letters in Organic Chemistry Somatic Genome Variations in Health and Disease
Current Genomics Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
Current Neuropharmacology Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
Current Alzheimer Research Editorial [Hot Topic: The Sleep-Wake Cycle, the Hypocretin/Orexin System and Narcolepsy: Advances from Preclinical Research to Treatment (Guest Editors: Oscar Arias-Carrion and Margaret Bradbury)]
CNS & Neurological Disorders - Drug Targets Neuropharmacology of the Olfactory Bulb
Current Molecular Pharmacology Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Current Cardiology Reviews Editorial (Thematic Issue: Treating Major Age-Related Diseases in Older and Oldest Old Patients)
Current Pharmaceutical Design Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV)
Current Topics in Medicinal Chemistry Endogenous Ligand Bias by Chemokines: Implications at the Front Lines of Infection and Leukocyte Trafficking
Endocrine, Metabolic & Immune Disorders - Drug Targets Epigenomic Approach in Understanding Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets At the “Junction” of Spinal Muscular Atrophy Pathogenesis: The Role of Neuromuscular Junction Dysfunction in SMA Disease Progression
Current Molecular Medicine